Rocket Pharmaceuticals (NASDAQ: RCKT) appoints new Principal Accounting Officer Filing Impact (High) Filing Sentiment (Neutral) Form Type Rhea-AI Filing Summary Rocket Pharmaceuticals, Inc. announced leadership changes in its finance organization. John Militello, VP of Finance, Senior Controller, Tr…
